REGISTERED
on 31 Dec 2024
Last Applicant/ Owned by
6055 Lusk Blvd.
San Diego
CA
92121
Serial Number
97844125 filed on 17th Mar 2023
Registration Number
7635112 registered on 31st Dec 2024
Correspondent Address
Danny M. Awdeh
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
CRINETICS PHARMACEUTICALS
Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical research services; scientific research and development; pharmaceutical research and development; therapeutic research and development, namely, research and development of therapeutic preparations; research and development in the field of oncology; medical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; pharmaceutical research for treating cancer, endocrine disorders, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, and chronic pain, hypercalcemia, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic research, namely, research of therapeutic preparations for ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and therapeutics
First Use Date in General
12th May 2021
First Use Date in Commerce
12th May 2021
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for modulating neuropeptides and G-protein coupled receptors (GPCRs); pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine related diseases; pharmaceutical preparations for targeting neuropeptide receptors; pharmaceutical preparations for the treatment of cancer, acromegaly, neuroendocrine tumors, Cushing's Disease, hyperinsulinism, carcinoid syndrome, congenital adrenal hyperplasia, hypercalcemia, chronic pain, hyperparathyroidism, polycystic kidney disease, Grave's disease, thyroid eye disease, thyroid ophthalmopathy, diabetes, obesity, insulinoma, hypoglycemia, androgen deficiency, infertility, thyroid cancer, growth hormone deficiency, hypoparathyroidism, nonfunctional pituitary adenomas, polycystic liver disease, and type two diabetes; therapeutic preparations for the treatment of ocular diseases and disorders, metabolic diseases and disorders, hormonal diseases and disorders, reproductive diseases and disorders, bone diseases and disorders, digestive diseases and disorders, gastroenterological diseases and disorders, and thyroid diseases and disorders
First Use Date in General
07th Dec 2018
First Use Date in Commerce
07th Dec 2018
Mark Details
Serial Number
No 97844125
Mark Type
No Service Mark
Attorney Docket Number
No 16187.0008
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Dec 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 31st Dec 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Dec 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 09th Dec 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 13th Nov 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 13th Nov 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 12th Sep 2024 | SOU EXTENSION 1 GRANTED |
| 12th Sep 2024 | SOU EXTENSION 1 FILED |
| 12th Sep 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Sep 2024 | SOU TEAS EXTENSION RECEIVED |